Showing 3,301 - 3,320 results of 9,650 for search 'significant ((((((gap decrease) OR (we decrease))) OR (greater decrease))) OR (mean decrease))', query time: 0.69s Refine Results
  1. 3301
  2. 3302
  3. 3303

    Summary of related studies. by Most. Fatematuz Zohora (19429152)

    Published 2024
    “…To address these challenges, we propose the Dynamic Banker’s Deadlock Avoidance Algorithm (DBDAA). …”
  4. 3304

    Time complexity of different safety algorithms. by Most. Fatematuz Zohora (19429152)

    Published 2024
    “…To address these challenges, we propose the Dynamic Banker’s Deadlock Avoidance Algorithm (DBDAA). …”
  5. 3305

    Process execution halted due to deadlock. by Most. Fatematuz Zohora (19429152)

    Published 2024
    “…To address these challenges, we propose the Dynamic Banker’s Deadlock Avoidance Algorithm (DBDAA). …”
  6. 3306

    Novel Small-Molecule miR-124 Inducer Acts as “a Physiological Brake” of Inflammation in Ulcerative Colitis by Targeting the PIK3R2/PI3K/Akt Axis by Tiantian Wang (1688881)

    Published 2025
    “…This study identified FHND5032, a novel small-molecule miR-124 inducer, as a potent therapeutic candidate for UC. We found that FHND5032 significantly upregulated miR-124 expression in macrophages, surpassing the clinical-stage comparator ABX464 in vitro and in vivo. …”
  7. 3307

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  8. 3308

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  9. 3309

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  10. 3310

    Specifications of prototypes of RSSCA system. by Ngoc-Hai Vu (22290844)

    Published 2025
    “…Compared to conventional PV systems, the RSSCA offers improved light uniformity, better land-use efficiency, and significantly higher electricity generation. However, in regions with limited direct sunlight, such as Seoul in winter, system performance decreases. …”
  11. 3311

    S1 Data - by Jessica C. M. Hui (20370522)

    Published 2024
    “…Compared to the SD, the HFD and SDG models exhibited significantly increased and decreased contraction velocities and could be used as models of diarrhoea and constipation in DM, respectively, while the ED model showed comparatively little change in motility. …”
  12. 3312

    Design of a RSSCA system for agriculture. by Ngoc-Hai Vu (22290844)

    Published 2025
    “…Compared to conventional PV systems, the RSSCA offers improved light uniformity, better land-use efficiency, and significantly higher electricity generation. However, in regions with limited direct sunlight, such as Seoul in winter, system performance decreases. …”
  13. 3313
  14. 3314
  15. 3315

    Modulating the Coordination Environment of Cu-Embedded Mo<i>X</i><sub>2</sub> (<i>X</i> = S, Se, and Te) Monolayers for Electrocatalytic Reduction of CO<sub>2</sub> to CH<sub>4</su... by Thamarainathan Doulassiramane (17382128)

    Published 2024
    “…We found that the catalytic activity is mainly due to the level of antibonding states filling between the Cu atom and *OCHOH intermediate. …”
  16. 3316
  17. 3317
  18. 3318
  19. 3319
  20. 3320